Companies /Healthcare

Tilray Brands Inc

NASDAQ: TLRY Drug Manufacturers - Specialty & Generic
$4.64
▼ $0.24 (−4.92%) today
Markets closed · 6:39pm ET

TLRY Coverage

Page 7
9:53am ET
Companies and Brands

Cannabis Stocks Scare Off Short Sellers

The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.

Chris Lange
6:05am ET
Companies and Brands

Resuscitating CannTrust Stock May Not Be Possible

Canadian cannabis grower CannTrust's headwinds include possible delisting from the New York Stock Exchange, overdue financial reports, a class-action lawsuit, black market competition and more.

Paul Ausick
4:21pm ET
Health and Healthcare

Tilray’s Q4 Up in Smoke

Tilray released fourth-quarter financial results after the closing bell on Monday. The company said that it had a net loss of $0.62 per share and $46.94 million in revenue, compared with consensus…

Chris Lange
1:40pm ET
Companies and Brands

How Organigram Stock Can Get Its Mojo Back

Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in…

Paul Ausick
11:00am ET
Companies and Brands

Is the Worst Over for CannTrust Stock?

A receding tide for the marijuana industry has lowered all ships, and each stock has felt the sting since the market boom in the fall of 2018. If CannTrust can weather the…

Chris Lange
7:45am ET
Companies and Brands

Why Tilray Stock Continues to Struggle

After last year's dreadful results among Canada's pot growers, short sellers are all over Tilray and its peers. Is there much hope that Tilray may be able to hold on?

Paul Ausick
12:35pm ET
Companies and Brands

Why Cronos and Tilray Have Crumbled

An analyst rating downgrade hit three marijuana stocks Monday morning, and a fourth was forced to announce a delay in filing quarterly documents with the appropriate U.S. and Canadian regulators.

Paul Ausick
1:45pm ET
Companies and Brands

Why Lack of Bad News Boosted Aurora Cannabis Stock

When Aurora Cannabis reported fiscal second-quarter results, missing from the report was a detailed accounting of expected impairment charges announced last week when Aurora reported former chief executive Terry Booth's sudden departure.

Paul Ausick
10:55am ET
Companies and Brands

Cannabis Short Interest Gets Even Higher

The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.

Chris Lange